Similar articles

• Postgenomics of Neisseria meningitidis for vaccines development.

  Bernardini G, Braconi D, Martelli P, Santucci A. Bernardini G, et al. Expert Rev Proteomics. 2007 Oct;4(5):667-77. doi: 10.1586/14789450.4.5.667. Expert Rev Proteomics. 2007. PMID: 17941821 Review.
• Meningococcal protein antigens and vaccines.

  Feavers IM, Pizza M. Feavers IM, et al. Vaccine. 2009 Jun 24;27 Suppl 2:B42-50. doi: 10.1016/j.vaccine.2009.05.001. Epub 2009 May 28. Vaccine. 2009. PMID: 19481315 Review.
• Identification of novel antigens that protect against systemic meningococcal infection.

  Sun Y, Li Y, Exley RM, Winterbotham M, Ison C, Smith H, Tang CM. Sun Y, et al. Vaccine. 2005 Jul 14;23(32):4136-41. doi: 10.1016/j.vaccine.2005.03.015. Epub 2005 Apr 14. Vaccine. 2005. PMID: 15964482
• Bioinformatics: how it is being used to identify bacterial vaccine candidates.

  Zagursky RJ, Olmsted SB, Russell DP, Wooters JL. Zagursky RJ, et al. Expert Rev Vaccines. 2003 Jun;2(3):417-36. doi: 10.1586/14760584.2.3.417. Expert Rev Vaccines. 2003. PMID: 12903807 Review.
• Immunogenicity of recombinant class 1 protein from Neisseria meningitidis refolded into phospholipid vesicles and detergent.

  Niebla O, Alvarez A, Martín A, Rodríguez A, Delgado M, Falcón V, Guillén G. Niebla O, et al. Vaccine. 2001 May 14;19(25-26):3568-74. doi: 10.1016/s0264-410x(01)00008-1. Vaccine. 2001. PMID: 11348724